EF
BIO icon

Empowered Funds’s Bio-Rad Laboratories Class A BIO Stock Holding History

Empowered Funds’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
4,380
+2,212
+102% +$627K 0.01% 1375
2026
Q1 		$604K Buy
+2,168
New +$624K ﹤0.01% 1574
2025
Q4 		– Sell
-1,493
Closed -$419K – 1105
2025
Q3 		$419K Buy
1,493
+97
+7% +$26.4K ﹤0.01% 1476
2025
Q2 		$337K Sell
1,396
-151
-10% -$35.7K ﹤0.01% 1460
2025
Q1 		$377K Buy
1,547
+199
+15% +$59.9K 0.01% 1329
2024
Q4 		$443K Buy
+1,348
New +$458K 0.01% 1233

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Empowered Funds's BIO Position: Q2 2026 in Review

Empowered Funds increased its Bio-Rad Laboratories Class A (BIO) stake by 102% in Q2 2026, buying an estimated $627K and bringing the position to 4,380 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #1375.

Empowered Funds first reported a position in BIO in Q4 2024 and has held it in 6 quarters since. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Empowered Funds held 4,380 shares of Bio-Rad Laboratories Class A worth $1.29M as of Q2 2026.
  • Empowered Funds bought 2,212 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $627K.
  • Bio-Rad Laboratories Class A made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1375 holding.
  • Empowered Funds first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and has held it in 6 quarters since.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.